BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35999808)

  • 21. Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
    Zhang X; Liu H; Zheng C; Tang B; Zhu X; Wan X; Tong J; Yao W; Song K; Sun Z
    Acta Haematol; 2021; 144(5):569-579. PubMed ID: 33849019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia.
    Rotz SJ; Wei W; Thomas SM; Hanna R
    Cancer; 2020 Dec; 126(24):5319-5327. PubMed ID: 32910494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
    Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia.
    Kaul S; Korgenski EK; Ying J; Ng CF; Smits-Seemann RR; Nelson RE; Andrews S; Raetz E; Fluchel M; Lemons R; Kirchhoff AC
    Cancer Med; 2016 Feb; 5(2):221-9. PubMed ID: 26714675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
    Stock W; La M; Sanford B; Bloomfield CD; Vardiman JW; Gaynon P; Larson RA; Nachman J; ;
    Blood; 2008 Sep; 112(5):1646-54. PubMed ID: 18502832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
    Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
    JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute lymphoblastic leukemia in young adults: which treatment?
    Anandappa A; Curran E
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):587-592. PubMed ID: 38066918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogammaglobulinemia in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
    Lange CS; Rahrig A; Althouse SK; Nelson RP; Batra S
    J Adolesc Young Adult Oncol; 2020 Dec; 9(6):687-692. PubMed ID: 32668180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
    Lalayanni C; Demosthenous C; Iskas M; Kelaidi C; Papathanasiou M; Syrigou A; Athanasiadou A; Papalexandri A; Batsis I; Vardi A; Polychronopoulou S; Sakellari I
    Leuk Lymphoma; 2022 Dec; 63(13):3128-3137. PubMed ID: 36002396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
    Advani AS; Larsen E; Laumann K; Luger SM; Liedtke M; Devidas M; Chen Z; Yin J; Foster MC; Claxton D; Coffan K; Tallman MS; Appelbaum FR; Erba H; Stone RM; Hunger SP; McNeer JL; Loh ML; Raetz E; Winick N; Carroll W; Larson RA; Stock W
    Blood Adv; 2021 Jan; 5(2):504-512. PubMed ID: 33496745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
    Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population-based study.
    Schulpen M; Goemans BF; Kaspers GJL; Raaijmakers MHGP; Zwaan CM; Karim-Kos HE
    Int J Cancer; 2022 Apr; 150(7):1101-1112. PubMed ID: 34913161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective.
    Derwich K; Brzezinski A; Karpenko C; Morar V; Atukoralalage U
    J Adolesc Young Adult Oncol; 2022 Feb; 11(1):1-5. PubMed ID: 34232789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
    White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia.
    Lee GE; Fisher BT; Xiao R; Coffin SE; Feemster K; Seif AE; Bagatell R; Li Y; Huang YS; Aplenc R
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):290-6. PubMed ID: 26582867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of treatment site in adolescents and young adults with central nervous system tumors.
    Wolfson J; Sun CL; Kang T; Wyatt L; D'Appuzzo M; Bhatia S
    J Natl Cancer Inst; 2014 Aug; 106(8):dju166. PubMed ID: 25178694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
    Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
    Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expenditures among young adults with acute lymphoblastic leukemia by site of care.
    Wolfson JA; Bhatia S; Ginsberg J; Becker LK; Bernstein D; Henk HJ; Lyman GH; Nathan PC; Puccetti D; Wilkes JJ; Winestone LE; Kenzik KM
    Cancer; 2021 Jun; 127(11):1901-1911. PubMed ID: 33465248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.